매출 성장 + 마진 확대 + FCF 양수
Positive매출이 +21.3% 성장하면서 영업이익률이 21.1%에서 21.2%로 확대되었다. FCF도 양수를 유지하여 질적 성장이 확인된다.
Evidence
매출 YoY +21.3%영업이익률 21.1%→21.2%FCF 16,019
Stormtec
A352090 · KOSDAQ₩3,555+1.14%
2026-08-03 closeStormtec — what's the grade? And what signals are flashing today?
Open the exact grade & valuation bands with Pro →Loading chart…
Close
AI Insight
Why these signals fired — only backtest-proven edge, told honestly
Strong-buy signal — the real recordrecord · not a prediction
Not this one stock, but every strong-buy pick we actually published (Korea market). When this stock flashes the signal, it is treated by the same rule.(as of 2026-08-03)
Last 30 sessions
648 picks
Next-day win rate
49.2%
Avg next-day
-0.17%
vs market
+0.72%p
Beat the market on 62.1% of picks (each pick vs its own day’s market average).
Recent publish days (next-day win rate)
07-31 0%07-30 66.7%07-29 0%07-28 45%07-27 20%07-25 36.4%07-21 55.6%07-20 53.8%07-16 53.3%07-15 50%07-14 71.4%07-13 31.2%
This stock has not flashed this signal recently — the record above is the signal’s own, not this stock’s.
Entry is the latest close at publish time; next-day is the following close. “Market” is the equal-weighted average of every stock in the same market that day; delisted names are excluded from both. Fees, taxes and slippage are not included. An observed record over a short window, not a pre-registered backtest. Not investment advice.
Valuation Grades
Relative to 110 화학 peers · not investment advice
Annual dividend
Split-adjusted annual DPS history and available grade axes
Consistency
D
Yield
A+
Paid 2 consecutive years · Raised 0 consecutive years · Yield 7.03% (based on 2025 payment of 250원)
Per-share amount adjusted for splits and capital reductions · Factual information, not investment advice.
Financial safety
Reference indicatorAs of 2024Safe zoneFinancial-metric reference signal
Altman Z'' zoneZ'' 8.17
Distress
Grey
Safe
- Altman Z''
- 8.17
- Beneish M-Score
- -1.90
- Sloan accrual
- 0.12%
No statistical flag
부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.
Factual information, not investment advice.
Why has this company moved this way?
Auditable observations with the original numeric evidence.
Factual information, not investment advice.
Earnings quality · Piotroski F-Score
3/9Weak
Piotroski measures year-over-year financial improvement, not absolute quality.
Financial improvement score3/9
Profitability
- Positive ROAPass
- Positive OCFPass
- Improving ΔROAPass
- Accruals (OCF > net income)Not passed
Leverage & liquidity
- Lower debtNot passed
- Higher current ratioNot passed
- No new sharesNot passed
Efficiency
- Higher gross marginNot passed
- Higher asset turnoverNot passed
Calculation note: F7(신주)은 equity/asset 유지로 근사
Already-stable companies may score lower when year-over-year improvement is limited.
Factual information, not investment advice.
Forensic signals
Anomaly and structural signals observed in the financial statements.
Balance sheetWarning
부채총계 급증 (+136%). 통계적 정황 신호이며 회계부정 단정이 아닙니다.
Factual information, not investment advice.
Industry structure
KRAs of 2026-08-03화학
This stock is in 화학: revenue rank 83 of 109, share 0%.
83 / 1090%revenue share
Who dominates this industry?
- 1LG화학31.9%
- 2롯데케미칼13.3%
- 3금호석유화학4.7%
- 4DL3.7%
- 5코오롱인더3.2%
- 6스톰테크0%
Concentration
DistributedCR3 49.9%HHI and CR3 are separate industrial-organization facts; they are not the polarization verdict.
Polarization
MixedConsistentPolarization measures industry gaps and structure, not valuation, forecast, or investment advice.
Margin lens
- IQR%p
- 8.66
- Direction
- 확대
- Level
- 보통
- Years
- 6
Value lens
- P90/P10
- 9.3
- Median P/B
- 0.71
- Level
- 넓음
- n
- 98
Survivorship note: 현재 산업 멤버십을 과거 연도에 소급 적용 — 과거 진입·퇴출 기업 미반영(복원 불가)
Factual information, not investment advice.
Risk sensitivity — adverse assumptions
Metric changes under stated assumptions; not a forecast or investment advice.
Base metrics
- Operating margin
- 21.2%
- Interest coverage
- 28.7x
- Return on equity (ROE)
- 16%
Operating margin −5pp
TolerableInterest coverageBase 28.7x adverse case 21.9x
Return on equity (ROE)Base 16% adverse case 11.5%
Revenue −15%
TolerableInterest coverageBase 28.7x adverse case 24.4x
Return on equity (ROE)Base 16% adverse case 12.9%
Interest rate +2pp
TolerableInterest coverageBase 28.7x adverse case 11.8x
Return on equity (ROE)Base 16% adverse case 14.5%
Interest coverage limit
Current margin 20.4ppInterest coverage limit at an operating margin of 0.7%
Interest expense coverage threshold
Key suppliers · Annual report
Annual reportDART · 2026-03-20Suppliers disclosed by the company in its 2026-03-20 annual report.
Suppliers without disclosed amount
LINEBoardCAPA
Financials at a glance
Stormtec's latest results and balance sheet. The bars track the last three periods.
Who held it · filings
Filed recordA historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.
US 13F는 분기 공시이며 최대 45일 뒤 제출될 수 있습니다.
5%+ major-holding disclosures
- 강기환70.97%2025-12-30 · 증감 +0.02%p
Connections
AI-extracted related companies · for reference
Customers
Same theme
소형가전
Recent filings
Stormtec's latest filings on Korea's DART. Open a headline for a reference summary and the original.
Source: DART (Korea electronic disclosure)
Signal history (last ~2 years)
Every occurrence on this stock, with the return 20 trading days later. Small sample — a record, not a prediction.
Golden cross×1
26-05-13-4.2%
New MA alignment×2
26-05-11-9.5%26-04-28-4.4%
“·” = fewer than 20 trading days since the event. Cup-and-handle entries are days our board actually showed the badge (archive grows daily since 2026-05-12); others are recomputed from price data.
Like these rules? Run them automatically.
Quantus turns rules like these into backtests and automated trading — same team, free to start.
Quantus Signal · live data · not investment advice · Privacy Policy